FDA's Role in the Medical Product Supply Chain and Considerations During COVID-19 [September 1, 2020] [open pdf - 2MB]
From the Background: "The Coronavirus Disease 2019 (COVID-19) pandemic has affected the medical product supply chain globally and domestically. Although certain concerns about the U.S. medical product supply chain predate the emergence of COVID-19, the ongoing pandemic has made addressing those concerns and understanding the supply chain a more urgent priority. Of particular concern for some are the United States' reliance on foreign sources of medical products and the federal government's ability to oversee the supply chain and mitigate future disruptions."
CRS Report for Congress, R46507
Congressional Research Service: https://crsreports.congress.gov/